FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078520 [Registered on: 24/12/2024] Trial Registered Prospectively
Last Modified On: 25/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Effect of homoeopathy in management of bronchial asthma in children aged 6-18 years. 
Scientific Title of Study   Effect of individualized homoeopathic medicine as an adjunct to conventional medication in the management of bronchial asthma among 6-18 years of age group: a prospective pre & post study. 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anjan choudhury 
Designation  Pg scholar 
Affiliation  Bakson homoeopathic medical college and hospitalL COLLEGE AND HOSPITAL 
Address  Depertment of pediatrics ground floor room no g20 bakson homoeopathic medical college and hospital b36 knowledge park 1 greater noida uttar pradesh.

Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  7001640944  
Fax    
Email  ANJANC8@GMAIL.COM  
 
Details of Contact Person
Scientific Query
 
Name  Dr Puneet garg  
Designation  Guide & professor and hod 
Affiliation  Bakson homoeopathic medical college and hospital 
Address  Depertment of pediatrics ground floor room no g20 bakson homoeopathic medical college and hospital b36 knowledge park 1 greater noida uttar pradesh

Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9411437669  
Fax    
Email  DRPUNEETGARG18@YAHOO.COM  
 
Details of Contact Person
Public Query
 
Name  Dr Ashwini nair 
Designation  Pg incharge 
Affiliation  BBakson homoeopathic medical college and hospital 
Address  Depertment of homoeopathic materia medica second floor room no 1 bakson homoeopathic medical college and hospital b36 knowledge park 1 greater noida uttar pradesh

Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9991078024  
Fax    
Email  PGINCHARGEBAKSON@GMAIL.COM  
 
Source of Monetary or Material Support  
Bakson homoeopathic medical college and hospital 36B knowledge park 1 greater noida gautam buddha nagar uttar pradesh 201310 india 
 
Primary Sponsor
Modification(s)  
Name  Bakson homoeopathic medical college and hospital 
Address  Principal office ground floor room no g 22 bkson homoeopthic medical college & hospital b36 knowledge park 1 greater noida uttar pradeh 201310 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anjan choudhury  Bakson homoeopathic medical college and hospital  Outpatient depertment (opd) room no 1 ground floor bakson homoeopathic medical college & hospital b 36 knowledge park 1 greater noida
Gautam Buddha Nagar
UTTAR PRADESH 
7001640944

ANJANC8@GMAIL.COM 
Dr Anjan choudhury  Dr. Dp rastogi central resarch institute of homoeopathy  Out patient depertment (opd) room no 110 ground floor a 1/1 sector 24 noida 201301
Gautam Buddha Nagar
UTTAR PRADESH 
7001640944

ANJANC8@GMAIL.COM 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Bakson institutional ethics committee  Approved 
Central council for research in homoeopathy  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J45||Asthma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized homeopathic medicine   Pill size 30. Oral route of administration. Centesimal scale first dose after case taking. Repetition according to follow-up 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  18.00 Year(s)
Gender  Both 
Details  Participant suffering with all types of asthma (allergic & non-allergic) and concurrent allergic condition.
Participant on bronchodilator & inhaler.
Spirometry values FEF(25-75%):
VALUES LESS THAN 70%
SIGNIFICANT RESPONSE TO BRONCHODIALOTOR (% IMPOVEMENT OVER BAELINE) : +25 
 
ExclusionCriteria 
Details  Participant with any other systemic disease or any immunocompromised condition.
Participant with severe psychiatric issue.
Participant who refused to give consent
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
It is expected that after giving individualized homoeopathic medicine there will be reduction in the score of ASTHMA APGAR SCORE.   Total 15 Months study
Enrollment Period – 6 Months
Follow Up – 6 Months
to be used at baseline, 2nd, 4th and 6th month.

 
 
Secondary Outcome  
Outcome  TimePoints 
SCALES: Asthma Quality of Life Questionnaire with Standardized Activities AQLQ(S).  to be used at baseline, 6th month. 
SPIROMETRY (FEF(25-75%))  to be used at baseline, 2nd, 4th and 6th month. 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is to assess the effectiveness of homoeopathic medicine in the management of bronchial asthma as an adjunct to conventional medication. 

Sample size 64

Single arm study: 15 months.

scale used for  screening : asthma apgar score.

Scale used for  assessment : asthma apgar score,  Asthma Quality of Life Questionnaire with Standardized Activities AQLQ(S). , SPIROMETRY (FEF(25-75%)

It is expected that to see positive changes in the asthma apgar score,  Asthma Quality of Life Questionnaire with Standardized Activities AQLQ(S). , SPIROMETRY (FEF(25-75%)


 
Close